Humacyte, Inc.

Healthcare · Biotechnology · United States

Last price 0.4112 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 114.23M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would tar...